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Objective: Our objective was to identify risk factors associated with 30-day mortality after isolated coronary artery
bypass grafting in the Australian context and to develop a preoperative model for 30-day mortality risk prediction.
Summary Background Data: Preoperative risk associated with cardiac surgery can be ascertained through
a variety of risk prediction models, none of which is specific to the Australian population. Recently, it was shown
that the widely used EuroSCORE model validated poorly for an Australian cohort. Hence, a valid model is
required to appropriately guide surgeons and patients in assessing preoperative risk.
Methods: Data from the Australasian Society of Cardiac and Thoracic Surgeons database project was used. All
patients undergoing isolated coronary artery bypass grafting between July 2001 and June 2005 were included for
analysis. The data were divided into creation and validation sets. The data in the creation set was used to develop
the model and then the model was validated in the validation set. Preoperative variables with a P value of less than
.25 in c2 analysis were entered into multiple logistic regression analysis to develop a preoperative predictive
model. Bootstrap and backward elimination methods were used to identify variables that are truly independent
predictors of mortality, and 6 candidate models were identified. The Akaike Information Criteria (AIC) and pre-
diction mean square error were used to select the final model (AusSCORE) from this group of candidate models.
The AusSCORE model was then validated by average receiver operating characteristic, the P value for the
Hosmer–Lemeshow goodness-of-fit test, and prediction mean square error obtained from n-fold validation.
Results: Over the 4-year period, 11,823 patients underwent cardiac surgery, of whom 65.9% (7709) had isolated
coronary bypass procedures. The 30-day mortality rate for this group was 1.74% (134/7709). Factors selected as
independent predictors in the preoperative isolated coronary bypass AusSCOREmodel were as follows: age, New
York Heart Association class, ejection fraction estimate, urgency of procedure, previous cardiac surgery, hyper-
cholesterolemia (lipid-lowering treatment), peripheral vascular disease, and cardiogenic shock. The average area
under the receiver operating characteristic was 0.834, the P value for the Hosmer–Lemeshow c2 test statistic was
0.2415, and the prediction mean square error was 0.01869.
Conclusion: We have developed a preoperative 30-day mortality risk prediction model for isolated coronary
artery bypass grafting for the Australian cohort.Risk models that predict mortality after isolated coronary
artery bypass grafting (CABG) have been developed in
a variety of patient populations. Widely known models
include the Parsonnet score (1989)1 and the European Sys-
tem for Cardiac Operative Risk Evaluation (EuroSCORE)
model.2 The latter aimed to predict 30-day mortality in
patients having cardiothoracic surgery. There are two Euro-
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additive,2 which can be calculated by hand, and the multiple
logistic,2 which is said to more accurately predict the risk in
‘‘high-risk’’ patients. The EuroSCORE has been validated in
many populations, including The Society of Thoracic Sur-
geons database,2 Japan,3 and Cologne, Germany.4
In populations with no derived prediction models, three
options can be used to estimate risk.5 These include (1)
adopting a ‘‘ready made’’ model such as the Parsonnet or
EuroSCORE, (2) ‘‘recalibrating’’ an existing model, using
the risk factors from a published index and adjusting the
weights so that it is relevant to the population, or (3) deriving
a local index from the population’s own surgical data set.
In Australia, the EuroSCORE model for risk adjustment is
themost widely used.However, recently Yap and colleagues6
have shown that the EuroSCORE model could not be vali-
dated for use in the Australian population. Furthermore,
Yap’s group6 showed that recalibration of the EuroSCORE
model did not provide an accurate model for the Australiangery c October 2009
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AIC ¼ Akaike Information Criteria
ASCTS ¼ Australian Society of Cardiac and
Thoracic Surgeons
CABG ¼ coronary artery bypass grafting
CI ¼ confidence intervals
EuroSCORE ¼ European System for Cardiac
Operative Risk Evaluation
MSE ¼ mean square error
NYHA ¼ New York Heart Association
ROC ¼ receiver operating characteristic
cohort and identified the need for a new model to be
developed that better reflected outcomes in the Australian
population.
Therefore, the aim of this study was to develop a new
model for predicting 30-day mortality after isolated CABG
for use in the Australian population. Our hypothesis was
that a locally derived model would provide a higher level
of discrimination and would be better calibrated than the cur-
rently most widely used risk prediction model.
METHODS
Database of the Australian Society of Cardiac and
Thoracic Surgeons
The Australian Society of Cardiac and Thoracic Surgeons (ASCTS) da-
tabase has prospectively collected information about adult patients having
cardiac surgery in 6 public hospitals in Victoria since June 2001. Each center
has a data manager who is responsible for the completeness of the data col-
lection. All data are verified on receipt, and data queries are generated from
missing data, outliers, or inconsistencies reported. Data validation has been
a major focus since the establishment of the ASCTS database in 2001. The
data were subjected to both local validation and an external data quality audit
program, which was performed on site to evaluate the completeness (<1%
missing data for any variable) and accuracy of the data housed within the
combined database. The outcome from the audit was used to assist in further
development of appropriate standards.7
The ASCTS database contains information on patient risk factors (in-
cluding preoperative cardiac status and previous interventions), intraopera-
tive details (including the procedure performed, myocardial protection, and
procedural durations), and postoperative outcomes. All patients undergoing
cardiac surgical procedures between July1, 2001, and June 30, 2005, were
included in the database. The index outcome was mortality, defined as death
within 30 days postoperatively. Thirty-day mortality information was ob-
tained by data managers contacting patients, family members, or medical
practitioners by telephone as part of clinical care.
Statistical Methods
All data were collected in a customized database, de-identified, and ex-
ported for data analysis. We have initially identified 20 variables as the risk
factors for the 30-day mortality. Six of these variables contain missing ob-
servations. The New York Heart Association (NYHA) class has the highest
rate of missing observations (6.91%) followed by ejection fraction estimate
(0.51%) and body mass index (0.18%). The variables creatinine history,
previous myocardial infarction, and cerebrovascular disease each have
less than 0.051%missing observations. Any patients with missing observa-
tions were excluded from the analysis. Stata version 9.2 and R version 2.3.1The Journal of Thoracic and Cwere used for the analysis.8,9 The data have been randomly divided into
model creation (n ¼ 5151, 67%) and model validation sets (n ¼ 2558,
33%). The creation set was used to develop the model, and then the perfor-
mance of the model was assessed in the validation set. The statistical signif-
icance for the independent association between a variable and 30-day
mortality was assessed by the c2 test. However, if the expected cell fre-
quency for the 2-by-2 table was smaller than 5, Fisher’s exact test was
used for the significance test. The inclusion criterion for a variable in the
c2 analysis was that any of the observed frequency (prevalence) in the 2-
way table must not be less than 1% in the data set. After c2 analysis, vari-
ables with a P value of less than 25% were selected as plausible predictors
into the multiple logistic regression model. We considered a P value of .25
as the threshold value for ongoing multiple logistic regression analyses in
accord with literature-based recommendations.10,11
Multiple logistic regression analysis and model development and testing
were conducted by the bootstrap method. The bootstrap method was based
on the random selection of 1000 repeated samples from the creation data set.
The backward eliminationmethod was used within each bootstrap sample to
develop a parsimonious predictivemodel.10 In the variable selection process
of backward elimination method, a P value of .05 or less was regarded as
significant. In all bootstrap samples, the number of times each candidate var-
iable was identified as a significant predictive variable was recorded and
then ranked. Six plausible multiple logistic regression models were devel-
oped on the basis of the proportion of times the variables were selected as
significant predictors. The candidate models contained the variables that
were identified as significant in at least 90%, 70%, 60%, 50%, 20%,
and 10% of the bootstrap samples.
The final model was selected using Akaike Information Criteria (AIC)
and prediction mean square error (MSE) obtained for the creation data.12
The performance of the candidate models was compared by average re-
ceiver operating characteristic (ROC), Hosmer–Lemeshow11 P value, and
prediction MSE calculated from n-fold (n¼ 50) validation in the validation
data set. The first-degree interaction effect between clinically relevant risk
factors and multicollinearity for all possible pairs of risk factors were also
investigated (Figure 1).
Assignment of additive scores to risk factors was based on a linear trans-
formation of the corresponding beta coefficient. The coefficient of each risk
factor was divided by .6065 (absolute value of the lowest beta coefficient for
hypercholesterolemia), multiplied by a constant of 2, and rounded to the
nearest integer.13
RESULTS
A total of 11,823 procedures have been recorded in the
ASCTS database from the commencement of recording,
and of those 65.9% (n ¼ 7709) were isolated CABG proce-
dures. Descriptive characteristics of these patients are shown
in Table 1. The average age of the patients was 65.7  10.1
years, and 76.8% of the patients were male. Elective surgery
was performed in 58.9% of the patients, urgent surgery in
36.5%, and emergency or salvage surgery in 4.52%. Only
3.7% of patients had previous CABG surgery and 4.4%
of patients had previous cardiac surgery.
The c2 analysis revealed 20 candidate variables for the 30-
day mortality for CABG: age, gender, preoperative dialysis,
creatinine level, respiratory disease, resuscitation less than
1 hour before the operation, use of inotropes, use of anticoagu-
lants, use of nitrates, urgency of procedure, NYHA class,
cerebrovascular disease, previous myocardial infarction,
hypertension, cardiogenic shock, hypercholesterolemia (lipid-
lowering treatment), ejection fraction estimate, peripheral vas-
cular disease, body mass index, and previous cardiac surgery.ardiovascular Surgery c Volume 138, Number 4 905
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FIGURE 1. Single-validation receiver operating characteristic (ROC) for AusSCORE model for creation (left) and validation (right) data sets.The results from bootstrap model selection are summa-
rized in Table 2.No variablewas identified as an independent
predictor of mortality in all 1000 bootstrap samples. Five
variables (age, NYHA class, ejection fraction estimate,
urgency of procedure, and previous cardiac surgery) were
identified in at least 90% of the bootstrap samples. Two
additional variables (hypercholesterolemia and peripheral
vascular disease) were selected in at least 70% of the
samples. One variable (cardiogenic shock) was identified
as an independent predictor in at least 60% of the samples.
Inotrope medication was selected in at least 50% of boot-
straps. The remaining 11 variables were selected as indepen-
dent predictors of CABG mortality in less than 50% of the
bootstrap samples.
We considered 6 plausible models on the basis of the pro-
portion of times the variables were selected as significant in
the bootstrap samples. For each model, the AIC and predic-
tion MSE in the creation data set were obtained and are pre-
sented in Table 3. Clearly, the model with variables selected
in at least 60% of the bootstrap samples gives the minimum
AIC and MSE. Thus we consider this model as our final
model, the AusSCORE. The risk factors in the AusSCORE
are as follows: age, NYHA class, urgency of procedure,
ejection fraction estimate, previous cardiac surgery, hyper-
cholesterolemia (lipid-lowering treatment), peripheral vas-
cular disease, and cardiogenic shock (Table 4). There was
no evidence of multicollinearity or first-order interaction
effect between the risk factors in the model. The beta
coefficients, odds ratio, and the additive risk score are also
presented in Table 4. The negative coefficient obtained for
hypercholesterolemia may be driven by the lipid-lowering
treatment. The average ROC, P value, and MSE in the val-
idation data set (n-fold validation), presented in Table 3,
shows that our selected model had ROC 0.834, P value
.2415, and MSE 0.01869. The model had the smallest pre-
diction error, hence the best prediction performance among
the candidate models.906 The Journal of Thoracic and Cardiovascular SurFor comparison with the EuroSCORE model, the ROC
(0.8363) and P value (.1477) were also calculated for the Aus-
SCOREmodel using a single validation in the validation data
set. The ROC and P value for Hosmer–Lemeshow c2 for
goodness-of-fit test for the AusSCORE model for the Austra-
lian data and the EuroSCORE model for its own data and in
the context of Australian data are presented in Table 5. The re-
sults suggest not only that the AusSCORE model calibrates
well and is a valid model, but that it performs better than
the EuroSCORE model. Actual versus predicted mortality
TABLE 1. Descriptive characteristics of patients undergoing isolated
CABG
Characteristics
Descriptive measure
(n ¼ 7709)
Age 65.7  10.1
Body mass index 28.2  4.6
Urgency of operation
Elective 58.9%
Urgent 36.5%
Emergency 4.2%
Salvage 0.32%
Ejection fraction
Normal 45.3%
Mild 31.3%
Moderate 17.9%
Severe 5.6%
Gender (male) 76.8%
Hypercholeterolemia 17.9%
Previous CABG 3.7%
Previous surgery 4.4%
Previous vascular disease 13.6%
Cardiogenic shock 1.6%
NYHA class
Class I 36.6%
Class II 31.7%
Class III 21.5%
Class IV 10.2%
CABG, Coronary artery bypass grafting; NYHA, New York Heart Association.gery c October 2009
Reid et al Acquired Cardiovascular Disease
A
C
Dfor different risk subsets, presented in Table 6, also show that
the AusSCORE model has a very good predicting perfor-
mance. In the validation set, the overall observed mortality
was 1.99% (95% confidence intervals [CI] 1.45%–2.53%)
and the predicted mortality was 1.53% (95% CI 1.05%–
2.0%). The low-risk group had an observed mortality of
0.20% (95% CI 0.0%–0.4%) and a predicted risk of
0.25% (95% CI 0.0%–0.47%). The medium-risk group
had an actual mortality of 1.04% (95% CI 0.51%–1.57%)
and a predicted mortality of 0.7% (95% CI 0.27%–
1.13%). The actual mortality for the high-risk group was
4.64% (95% CI 3.56%–5.72%) and the predicted mortality
was 4.08% (95% CI 3.06%–5.10%).
The estimated beta coefficients for the AusSCORE model
reported in Table 4 can easily be used to predict the 30-day
mortality risk for a patient undergoing cardiac surgery. Let
us consider that a 75-year-old patient (beta coefficient is
1.2684) has the following 4 preoperative risk factors:
NYHA class III (beta coefficient is .7383), urgent procedure
type (beta coefficient is .8760), moderate ejection fraction
estimate (beta coefficient is .7782), and peripheral vascular
disease (beta coefficient is .7480). The constant term of the
AusSCORE model is6.2913. The sum of the beta coeffi-
cients and the constant term is1.8824. Hence the predicted
risk of 30-day mortality for this patient is as follows: pre-
dicted risk ¼ (exp[1.8824])/(1þ exp[1.8824]) ¼ 0.1321,
or 13.21% (95% CI 3.4%–40%).
Additive risk score was also derived from the beta coeffi-
cients of the AusSCORE model (see Table 4) and additive
risk categories were defined. The categories are as follows:
TABLE 2. Number of times each candidate variable was selected in
1000 bootstrap samples drawn from the model creation dataset.
Variable Frequency %
Age group 982 98.2
NYHA class 955 95.5
Urgency of procedures 949 94.9
Ejection fraction estimate 948 94.8
Previous cardiac surgery 910 90.1
Hypercholesterolemia 787 78.7
Peripheral vascular disease 748 74.8
Cardiogenic shock 698 69.8
Medications: inotropes 558 55.8
Hypertension 495 49.5
Gender 476 47.6
Body mass index group 351 35.1
Creatinine level>0.133 mmol/L 337 33.7
Preoperative dialysis 323 32.3
Resuscitation<1 hour preoperatively 322 32.2
Medications: nitrates 252 25.2
Medications: anticoagulants 239 23.9
Respiratory disease 188 18.8
Previous myocardial infarction 185 18.5
Cerebrovascular disease 180 18.0
NYHA, New York Heart Association.The Journal of Thoracic and Cless than 3, low risk (actual mortality rate 0.2%); 3 to 5,
moderate risk (actual mortality rate 1.04%); and above 5,
high risk (actual mortality rate 4.64%). The risk categories
can easily be used to identify a patient’s risk of 30-day mor-
tality before the operation. A c2 test showed that there is
a strong association between mortality and risk categories
(P< .001), which demonstrates that the mortality rates in
the high-risk categories are significantly higher than in the
low-risk categories. The discrimination ability of the addi-
tive model (ROC 0.837 and 95% CI 0.7840–0.899) was
also very good and was similar to that of the logistic model
(ROC 0.8363 and 95% CI 0.7827–0.8898).
A validation of the AusSCORE model for all procedures
data (isolated CABG, valve[s] only, valve[s]þCABG, and
others) showed that the global discrimination and calibration
performances of the model were also very good (ROC ¼
0.8178 and Hosmer–Lemeshow P value ¼ .5910; overall
actual mortality ¼ 3.5%, overall predicted mortality
¼ 2.1%). Thus the AusSCORE model can also be used to
predict risk of 30-day mortality for the patients undergoing
cardiac operations other than CABG as well.
DISCUSSION
This is the first article to provide a well-validated model
for the prediction of 30-day mortality after isolated CABG
surgery in an Australian population. It will allow for a better
assessment of preoperative risk for both surgeons and
patients to consider.
In the CABG risk model literature, the ROC for predictive
models varies from 0.779 to 0.836.14-19 Thus the perfor-
mance of our proposed AusSCORE model with 8 variables
(single validation: ROC ¼ 0.8363 and P value ¼ .1477;
n-fold validation: ROC ¼ 0.8340 and P value ¼ .2415) is
comparable with the models reported in the literature and
is better than the EuroSCORE model for its own data and
especially for the Australian data. The need for a local risk
model has been highlighted in the recent reports from
Bidstrup,20 Yap,21 and their associates. In addition, Nashef22
(2006) recently flagged that one reason that the EuroSCORE
TABLE 3. Average ROC, Hosmer–Lemeshow P value, and prediction
MSE in an n-fold (n ¼ 50) validation for the candidate models
Creation data set Validation data set
Percent of time
variables in the
bootstrap models AIC MSE ROC
H-L
P value MSE
At least 90% 668.3 0.01874 0.836 .1323 0.01888
At least 70% 660.7 0.01870 0.837 .2730 0.01885
At least 60% 657.8 0.01852 0.834 .2415 0.01869
At least 50% 657.8 0.01852 0.831 .1153 0.01878
At least 20% 661.9 0.01870 0.840 .3130 0.01888
At least 10% (all) 669.4 0.01871 0.838 .1243 0.01890
ROC, Receiver operating characteristic; AIC,Akaike Information Criteria;MSE,mean
square error; H-L, Hosmer–Lemeshow.ardiovascular Surgery c Volume 138, Number 4 907
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DTABLE 4. Beta coefficients (beta), odds ratio, and additive score for the preoperative isolated CABG AusSCORE model
Risk factors Beta P value OR 95% CI Score
Age group
<60 (reference) 1.00
60–70 .7487 .091 2.11 (0.89, 5.03) 2
70–80 1.2684 .002 3.56 (1.60, 7.91) 4
80þ 1.7318 .000 5.65 (2.13, 14.98) 6
NYHA class
Class I & II (reference) 1.00
Class III .7383 .016 2.09 (1.15, 3.82) 2
Class IV 1.1998 .000 3.12 (1.81, 6.08) 4
Urgency of procedure
Elective (reference) 1.00
Urgent .8760 .003 2.40 (1.34, 4.29) 3
Emergency/salvage 1.4226 .012 4.15 (1.83, 9.38) 5
Ejection fraction
Normal/mild (reference) 1.00
Moderate (30–45) .7782 .006 2.18 (1.25, 3.81) 3
Severe (<30) 1.2598 .000 2.52 (1.86, 6.68) 4
Previous surgery .8305 .033 2.29 (1.07, 4.92) 3
Hypercholesterolemia .6065 .021 0.55 (0.33, 0.91) 2
Peripheral vascular disease .7480 .005 2.11 (1.26, 3.54) 2
Cardiogenic shock 1.0100 .021 2.74 (1.16, 6.47) 3
Constant 6.2913 .000 N/A N/A N/A
CABG, Coronary artery bypass grafting; OR, odds ratio; CI, confidence intervals; NYHA, New York Heart Association; N/A, not applicable. Score: Assignment of scores to risk
factors was based on a linear transformation of the corresponding beta coefficient. The coefficient of each risk factor was divided by 0.6065 (absolute value of the lowest beta
coefficient for hypercholesterolemia), multiplied by a constant of 2, and rounded to the nearest integer.Definitions: NYHA class I to IV: I: Patients with cardiac disease but without
resulting limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitations, or dyspnea. II: Patients with cardiac disease resulting in slight lim-
itation of physical activity. They are comfortable at rest. Ordinary physical activity results in fatigue, palpitations, or dyspnea. III: Patients with cardiac disease resulting in marked
limitation of physical activity. They are comfortable at rest. Less than ordinary physical activity results in fatigue, palpitations, or dyspnea. IV: Patients with cardiac disease resulting
in inability to carry on any physical activity without discomfort. Symptoms of cardiac insufficiency may be present even at rest. If any physical activity is undertaken, discomfort is
increased. Urgency of procedure: Not routine—medical reason for operating on this admission (1) within 72 hours from angiography if on the same admission that angiography
was performed (in this case, ‘‘same admission’’ includes the situation when angiography is performed at another hospital and the patient is transferred directly to the hospital where
surgery is to be performed) or (2) within 72 hours after an unplanned admission (in a patient who had a previous angiogram and was scheduled for surgery but was admitted acutely).
Ejection fraction: The percentage of the blood emptied from the left ventricle at the end of the contraction. Use the most recent determination before intervention. Enter a per-
centage in the range of 5 to 90. Previous CABG: Previous coronary artery bypass surgery by any approach. Hypercholesterolemia: Whether the patient has a history of hyper-
cholesterolemia diagnosed and/or treated by a physician, and/or cholesterol level greater than 5.0 mmol. Peripheral vascular disease: Whether the patient has peripheral vascular
disease, as indicated by claudication either with exertion or rest; amputation for arterial insufficiency; aortoiliac occlusive disease reconstruction; peripheral vascular bypass surgery,
angioplasty, or stent; documented abdominal aortic aneurysm, abdominal aortic aneurysm repair, or stent; positive noninvasive testing documented. Cardiogenic shock: Is the
patient, at the time of the procedure, in a clinical state of hypoperfusion according to either of the following criteria: (1) systolic blood pressure  80 and/or cardiac index 
1.8 despite maximal treatment; (2) intravenous inotropes and/or intra-aortic balloon pumping necessary to maintain systolic blood pressure>80 and/or cardiac index>1.8?did not calibrate well to the Australian population was that
the model is now over 10 years old and may not be appropri-
ate for identifying risk in a contemporary cohort. The newly
derived AusSCORE model will be valuable for providing
preoperative 30-day mortality risk evaluation for surgeons
and patients as well as providing a method for risk-adjusting
surgical performance outcomes for quality assurance. The
TABLE 5. Comparison between AusSCORE and EuroSCORE models
(single validation in the validation data set)
Validation Creation
Model ROC
H-L
P value ROC
H-L
P value
AusSCORE 0.8363 .1477 0.8393 .2871
EuroSCORE 0.7590 .6775 0.7875 .4085
EuroSCORE in Australian data 0.8200 <.05 N/A N/A
ROC,Receiver operating characteristic;H-L,Hosmer–Lemeshow;N/A, not applicable.908 The Journal of Thoracic and Cardiovascular SurAusSCORE model also performs well for the other surgical
procedures (eg, valve[s] only, CABGþvalve[s]). However,
we plan to develop a separate risk prediction model for the
Australian population using all procedures in a future study.
We hope the new model will be more appropriate to predict
30-day mortality for global (all procedure types) cardiac sur-
gery in Australia.
The methodologic approach of using bootstrap methods
for developing predictive models for mortality was proposed
to minimize the impact of automated variable selection
methods. Automated selection methods have been shown
to select noise variables as independent predictors, and these
are likely to change on repeated (bootstrap) analyses.10
Hence, one should not rely solely on assessing the statistical
significance of the predictors obtained by automated variable
selection methods, because the related P values are biased
downward.23 In contrast, the bootstrap method can be usedgery c October 2009
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indeed an independent predictor in the model. It is
expected that the truly independent predictors would be
selected in the majority of the bootstrap samples; however,
noise variables would be identified as independent predictors
in a minority of samples. The methods adopted in the present
analyses have provided a stable AusSCORE model that has
been shown to perform better than the current conventional
risk prediction models. Five risk factors—age, urgency of
operation, ejection fraction estimate, previous cardiac sur-
gery, and peripheral vascular disease—appeared in both
EuroSCORE and AusSCORE models. The absence of other
EuroSCORE variables in the AusSCORE may be related to
their association with non-CABG surgical outcomes.
A limitation of the current study may be the relatively lim-
ited number of cases included in the ASCTS database. How-
ever, with the 6 public hospitals contributing to the data set,
the analysis was undertaken after 4 years of collection, and
one may argue that further delay may result in the lack of
a contemporary data set for development. In addition, the
data were collected in one Australian state and not across
all states. This will be avoided through expansion of the
ASCTS database to include surgical units across Australia,
and we would propose a review of the AusSCORE after
the compilation of 20,000 cases.
CONCLUSIONS
We have developed an 8-variable AusSCORE model for
predicting 30-day mortality for isolated CABG procedures
TABLE 6. Actual and AusSCORE predicted mortality and 95% CI in
the validation set
Risk factors Actual (%) Predicted (%)
Overall 1.99 (1.45–2.53) 1.53 (1.05–2.00)
Gender
Male 2.63 (1.32–3.94) 1.73 (0.66–2.80)
Female 1.81 (1.22–2.40) 1.48 (0.95–2.01)
Age group
<60 0.97 (0.25–1.70) 0.62 (0.05–1.19)
60–70 1.29 (0.53–2.05) 1.16 (0.44–1.88)
70–80 2.98 (1.83–4.13) 2.23 (1.23–3.23)
80þ 5.37 (1.75–9.00) 4.09 (0.91–7.27)
Urgency of procedure
Elective 0.81 (0.35–1.27) 0.59 (0.20–0.98)
Urgent 2.52 (1.52–3.52) 2.10 (1.19–3.01)
Emergency and salvage 12.82 (6.76–18.88) 8.88 (3.73–14.03)
NYHA class
Class I & II 1.35 (0.79–1.91) 0.74 (0.32–1.16)
Class III 2.44 (1.13–3.75) 2.05 (0.85–3.25)
Class IV 5.94 (2.81–9.07) 6.21 (3.01–9.41)
Additive score
<3 (low risk) 0.20 (0.00–0.40) 0.25 (0.00–0.47)
3–5 (medium risk) 1.04 (0.51–1.57) 0.70 (0.27–1.13)
>5 (high risk) 4.64 (3.56–5.72) 4.08 (3.06–5.10)
CI, Confidence intervals; NYHA, New York Heart Association.The Journal of Thoracic and Cin Australia. The strength of the AusSCORE model com-
pared with similar models in the literature is the use of boot-
strap methods for variable selection. This provides a highly
consistent set of predictor variables associated with 30-day
mortality after isolated CABG surgery. The performance
of the AusSCORE model is found to be better than that of
the EuroSCORE model for its own data and its application
to the Australian data. All of the risk factors identified in
the AusSCORE model are generally considered as risk fac-
tors by most cardiac surgeons and cardiologists. However,
a risk prediction model based on the Australian data was
overdue inasmuch as the EuroSCORE model did not cali-
brate well for the Australian data. We recommend the use
of the AusSCORE model for the Australian cohort.
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